1,3-dipropyl-8-cyclopentylxanthine has been researched along with Dementia Praecox in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Villar-Menéndez, I | 1 |
Díaz-Sánchez, S | 1 |
Blanch, M | 1 |
Albasanz, JL | 1 |
Pereira-Veiga, T | 1 |
Monje, A | 1 |
Planchat, LM | 1 |
Ferrer, I | 1 |
Martín, M | 1 |
Barrachina, M | 1 |
Lillrank, SM | 1 |
Lipska, BK | 1 |
Weinberger, DR | 1 |
Fredholm, BB | 1 |
Fuxe, K | 1 |
Ferré, S | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Dementia Praecox
Article | Year |
---|---|
Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.
Topics: Actins; Adenosine A1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cell M | 2014 |
Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Corpus Striatum; Disease Models, Anim | 1999 |